# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-115492
Filing Date
2023-04-25
Accepted
2023-04-25 17:02:06
Documents
5
Period of Report
2023-06-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d439021ddef14a.htm | DEF 14A | 530001
2 | GRAPHIC | g439021g02.jpg | GRAPHIC | 284849
3 | GRAPHIC | g439021g03.jpg | GRAPHIC | 299817
4 | GRAPHIC | g439021g17d94.jpg | GRAPHIC | 78339
5 | GRAPHIC | g439021g46x63.jpg | GRAPHIC | 654046
| Complete submission text file | 0001193125-23-115492.txt |  | 2328177

Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33038 | Film No.: 23845699
SIC: 2834 Pharmaceutical Preparations